C-reactive protein contributes to the hypercoagulable state in coronary artery disease

被引:24
|
作者
Song, CJ
Nakagomi, A
Chandar, S
Cai, H
Lim, IGS
McNeil, HP
Freedman, SB
Geczy, CL [1 ]
机构
[1] Univ New S Wales, Sch Med Sci, Inflammatory Dis Res Unit, Sydney, NSW 2052, Australia
[2] Concord Hosp, Dept Cardiol, Sydney, NSW, Australia
[3] Univ Sydney, Anzac Res Inst, Vasc Biol Lab, Sydney, NSW 2006, Australia
[4] Univ New S Wales, Prince Wales Hosp, Dept Rheumatol, Sydney, NSW, Australia
关键词
C-reactive protein; coronary disease; inflammation; thrombosis; tissue factor;
D O I
10.1111/j.1538-7836.2005.01705.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Elevated plasma C-reactive protein (CRP) levels predict coronary events, but it is unclear whether CRP plays a role in thrombosis associated with these events. We investigated tissue factor (TF) induction by CRP on peripheral blood mononuclear cells (PBMC) from patients with coronary disease. Patients and Methods: PBMC from 35 patients with stable angina (SA) in study 1, 10 male patients with SA, 10 with unstable angina (UA) and 10 matched controls in study 2, and 25 patients with inflammatory disorders (ID) and 24 normal controls in study 3 were stimulated with CRP, interferon-gamma (IFN) or lipopolysaccharide (LPS), or their combination. PBMC from additional normal donors were also stimulated with CRP in adherent and non-adherent conditions, and TF activity, antigen and mRNA expression detected. Results: CRP (5-25 mu g mL(-1)) dose dependently induced more TF on PBMC from SA patients than 42 contemporary controls (P = 0.001, study 1). Compared with controls, patients with SA or UA had higher basal, and much higher CRP- or CRP/LPS-induced monocyte TF activity although serum CRP levels were similar (study 2). IFN induced monocyte TF activity in patients with angina, but not in controls. Basal or CRP-induced TF levels did not differ between controls and ID, even though ID patients had much higher serum CRP levels (study 3). CRP-induced monocyte TF activity correlated with serum CRP levels in controls (P = 0.005) and ID (P = 0.007) in study 3, but not in patients with angina (P =0.84) in study 2. CRP induced more TF activity, protein and mRNA under adherent than non-adherent conditions implying that it may mainly target macrophages in lymphocyte-rich lesions. Conclusions: Our results indicate that monocytes from patients with angina are preactivated and express TF but CRP is unlikely to be a major priming factor in vivo. IFN and CRP further increase TF levels that may contribute to the hypercoagulable state in coronary disease.
引用
收藏
页码:98 / 106
页数:9
相关论文
共 50 条
  • [31] C-reactive protein is an independent predictor of the presence and severity of coronary artery disease
    Alber, H. F. W.
    Ladurner, A.
    Doerler, J.
    Suessenbacher, A.
    Frick, M.
    Falkensammer, G.
    Pachinger, O.
    Weidinger, F.
    EUROPEAN HEART JOURNAL, 2006, 27 : 358 - 358
  • [32] C-reactive protein and rapidly progressive coronary artery disease - Is there any relation?
    Zairis, MN
    Manousakis, SJ
    Stefanidis, AS
    Vitalis, DP
    Tsanis, EM
    Hadjigeorgiou, SM
    Fakiolas, CN
    Pissimissis, EG
    Olympios, CD
    Foussas, SG
    CLINICAL CARDIOLOGY, 2003, 26 (02) : 85 - 90
  • [33] Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease
    Wascher, T. C.
    JOURNAL FUR KARDIOLOGIE, 2005, 12 (3-4): : 68 - 69
  • [34] C-REACTIVE PROTEIN DETERMINATION AS AN INDEX OF MYOCARDIAL NECROSIS IN CORONARY ARTERY DISEASE
    KROOP, IG
    SHACKMAN, NH
    AMERICAN JOURNAL OF MEDICINE, 1957, 22 (01): : 90 - 98
  • [35] PLASMA MYELOPEROXIDASE AND C-REACTIVE PROTEIN IN STABLE CORONARY ARTERY DISEASE PATIENTS
    Sawicki, M.
    Kozinski, M.
    Gruszka, M.
    Obonska, K.
    Pilaczynska-Cemel, M.
    Sypniewska, G.
    Kubica, J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S336 - S336
  • [36] Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease
    不详
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2005, 12 (02): : 188 - 188
  • [37] Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease
    Nissen, SE
    Tuzcu, EM
    Schoenhagen, P
    Crowe, T
    Sasiela, WJ
    Tsai, J
    Orazem, J
    Magorien, RD
    O'Shaughnessy, C
    Ganz, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (01): : 29 - 38
  • [38] Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease
    Tomai, F
    Ribichini, F
    Ghini, AS
    Ferrero, V
    Andò, G
    Vassanelli, C
    Romeo, F
    Crea, F
    Chiariello, L
    EUROPEAN HEART JOURNAL, 2005, 26 (20) : 2099 - 2105
  • [39] Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium
    Qureshi, Waqas T.
    Rana, Jamal S.
    Yeboah, Joseph
    bin Nasir, Usama
    Al-Mallah, Mouaz H.
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (12)
  • [40] Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease
    Arroyo-Espliguero, Ramon
    Avanzas, Pablo
    Quiles, Juan
    Kaski, Juan Carlos
    ATHEROSCLEROSIS, 2009, 204 (01) : 239 - 243